342 related articles for article (PubMed ID: 28579310)
1. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
[TBL] [Abstract][Full Text] [Related]
2. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
[TBL] [Abstract][Full Text] [Related]
3. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
Mirna M; Rohm I; Jirak P; Wernly B; Bäz L; Paar V; Kretzschmar D; Hoppe UC; Schulze PC; Lichtenauer M; Jung C; Franz M
Heart Lung Circ; 2020 Mar; 29(3):337-344. PubMed ID: 31327702
[TBL] [Abstract][Full Text] [Related]
5. Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.
Jirak P; Pistulli R; Lichtenauer M; Wernly B; Paar V; Motloch LJ; Rezar R; Jung C; Hoppe UC; Schulze PC; Kretzschmar D; Braun-Dullaeus RC; Bekfani T
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32326570
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
7. New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction.
Dalos D; Spinka G; Schneider M; Wernly B; Paar V; Hoppe U; Litschauer B; Strametz-Juranek J; Sponder M
J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31252588
[TBL] [Abstract][Full Text] [Related]
8. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
10. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
[TBL] [Abstract][Full Text] [Related]
11. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2.
Stojkovic S; Kaider A; Koller L; Brekalo M; Wojta J; Diedrich A; Demyanets S; Pezawas T
J Cell Mol Med; 2018 Apr; 22(4):2422-2429. PubMed ID: 29397580
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
[TBL] [Abstract][Full Text] [Related]
13. Serum heart-type fatty acid-binding protein decreases and soluble isoform of suppression of tumorigenicity 2 increases significantly by long-term physical activity.
Sponder M; Lichtenauer M; Wernly B; Paar V; Hoppe U; Emich M; Fritzer-Szekeres M; Litschauer B; Strametz-Juranek J
J Investig Med; 2019 Jun; 67(5):833-840. PubMed ID: 30593542
[TBL] [Abstract][Full Text] [Related]
14. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.
Rabkin SW; Tang JKK
Heart Fail Rev; 2021 Jul; 26(4):799-812. PubMed ID: 32472523
[TBL] [Abstract][Full Text] [Related]
15. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
[TBL] [Abstract][Full Text] [Related]
16. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
17. Variability of biomarkers in patients with chronic heart failure and healthy controls.
Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
[TBL] [Abstract][Full Text] [Related]
18. Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
Andersson C; Enserro D; Sullivan L; Wang TJ; Januzzi JL; Benjamin EJ; Vita JA; Hamburg NM; Larson MG; Mitchell GF; Vasan RS
Atherosclerosis; 2016 May; 248():245-51. PubMed ID: 26972631
[TBL] [Abstract][Full Text] [Related]
19. Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI).
Mirna M; Wernly B; Paar V; Jung C; Jirak P; Figulla HR; Kretzschmar D; Franz M; Hoppe UC; Lichtenauer M; Lauten A
Biomarkers; 2018 Dec; 23(8):773-780. PubMed ID: 30041555
[TBL] [Abstract][Full Text] [Related]
20. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
